Advertisement

Pharmacogenetics, the next challenge for pharmacy?

  • Jessica P. ClemersonEmail author
  • Katherine Payne
  • Paul Bissell
  • Claire Anderson
Commentary

Abstract

This commentary draws attention to and raises awareness of forthcoming pharmacogenetic technologies amongst the pharmacy profession. It aims to stimulate debate around the potential role that the pharmacy profession can play in the introduction of pharmacogenetic technologies into primary healthcare. This commentary discusses potential new roles for pharmacists involving pharmacogenetic technologies, giving attention to the way the profession may need to adapt to accommodate these.

Keywords

Pharmacists Pharmacogenetics Pharmacogenomics Pharmacy practice 

References

  1. 1.
    Evans WE, McLeod HL. Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med 2003;348(6):538–549.CrossRefPubMedGoogle Scholar
  2. 2.
    Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286:487–491.CrossRefPubMedGoogle Scholar
  3. 3.
    The Royal Society. Personalised medicines: hopes and realities. London, The Royal Society; 2005.Google Scholar
  4. 4.
    Mrtek RG, Catizone C. Pharmacy and the professions. In: Wertheimer AI, Smith MC (eds) Pharmacy practice: social and behavioural aspects. London: Williams and Wilkins; 1989. p. 23–41. ISBN 0683089323.Google Scholar
  5. 5.
    Nuffield Committee of Inquiry into Pharmacy. Pharmacy: a report to the Nuffield Foundation. London: Nuffield Foundation; 1986.Google Scholar
  6. 6.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533–543.PubMedGoogle Scholar
  7. 7.
    Nelson R. Genome Pharmacy: The Human Genome Project will have far-reaching ramifications for pharmacy practice. Hospital Pharmacist Report, 2000;October 2000:22-4.Google Scholar
  8. 8.
    Maitland-van der Zee A, de Boer A, Leufkens HGM. Pharmacogenetics and the Role of the Pharmacist. J Res Pharmaceut Econ 2001;11(3/4):143–150.CrossRefGoogle Scholar
  9. 9.
    Penick Brock T, Valgus JM, Smith SR, Summers KM. Pharmacogenomics: implications and considerations for pharmacists. Pharmacogenomics 2003;4(3):321–330.CrossRefGoogle Scholar
  10. 10.
    Johnson JA, Bootman JL et al. Pharmacogenetics: a scientific revolution in Pharmaceutical Sciences and Pharmacy Practice. Report of the 2001–2002 Academic Affairs Committee. Am J Pharm Educ 2002;66:12S–15S.Google Scholar
  11. 11.
    Maitland-van der Zee A, Klungel OH, de Boer A. Pharmacogenetics in health-care practice. Pharm World Sci 2004;26:253–255.CrossRefPubMedGoogle Scholar
  12. 12.
    Cryan SA. Pharmacy’s role in the Genomic Revolution Part 2: pharmacogenomics. Ir Pharm J 2004;March 2004:130-34.Google Scholar
  13. 13.
    Dotson Jaggers L. Pharmacogenomics: worthy of pharmacy’s attention. Am J Health-Syst Pharm 1999;56:27.Google Scholar
  14. 14.
    Akhtar S. Pharmacogenomics: are pharmacists ready for genotyped prescribing? Pharm J 2002;268:296–299.Google Scholar
  15. 15.
    Ensom MHH, Chang TKH, Patel P. Pharmacogenetics—the therapeutic drug monitoring of the future? Clin Pharmacokinet 2001;40(11):783–802.CrossRefPubMedGoogle Scholar
  16. 16.
    Humma LM, Terra SG. Pharmacogenetics and cardiovascular disease: Impact on drug response and applications to disease management. Am J Health-Syst Pharm 2002;59(13):1241–1252.PubMedGoogle Scholar
  17. 17.
    Morley KI, Hall WD. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations. J Mol Med 2004;82:21–30.CrossRefPubMedGoogle Scholar
  18. 18.
    Alcalde MG, Rothstein MA. Pharmacogenomics: ethical concerns for research and pharmacy practice. Am J Health-Syst Pharm 2002;59:2239–2240.PubMedGoogle Scholar
  19. 19.
    Sansgiry SS, Kulkarni AS. Genetic testing: the community pharmacist’s perspective. J Am Pharm Assoc 2004;44(3):399–402.CrossRefGoogle Scholar
  20. 20.
    Sansgiry SS, Kulkarni AS. The human genome project: assessing confidence in knowledge and training requirements for community pharmacists. Am J Pharm Educ 2003;67(2):91–93.Google Scholar
  21. 21.
    Zachry WM, Armstrong EP. Health care professionals’ perceptions of the role of pharmacogenomic data. J Manag Care Pharm 2002;8(4):278–284.PubMedGoogle Scholar
  22. 22.
    Vizirianakis IS. Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine. Eur J Pharm Sci 2002;15:243–250.CrossRefPubMedGoogle Scholar
  23. 23.
    Carrico JM. Human Genome Project and Pharmacogenomics: implications for pharmacy. J Am Pharm Assoc 2000;40(1):115–116.Google Scholar
  24. 24.
    Burton H, Shuttleworth A. Genetics education for pharmacists. Pharm J 2003;270(7232):84–85.Google Scholar
  25. 25.
    Penick Brock T, Faulkner CM, Williams DM, Smith SR. Continuing-education programs in pharmacogenomics for pharmacists. Am J Health-Syst Pharm 2002;59:722–725.Google Scholar
  26. 26.
    Latif DA, McKay AB. Pharmacogenetics and pharmacogenomics instruction in colleges and schools of pharmacy in the United States. Am J Pharm Educ 2005;69(2):Article 23.Google Scholar
  27. 27.
    Hapgood R. The potential and limitations of personalised medicine in primary care. Br J Gen Pract 2003;December:915-16.Google Scholar
  28. 28.
    Tavadia SM, Mydlarski PR, Reis MD, et al. Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case. J Am Acad Dermatol 2000;42:628–632.CrossRefPubMedGoogle Scholar
  29. 29.
    Shah J. Criteria influencing the clinical uptake of pharmacogenomic strategies. BMJ 2004;328:1482–1486.CrossRefPubMedGoogle Scholar
  30. 30.
    Prescription Pricing Authority. Volume and cost of prescribing. In: Prescription Pricing Authority: Internet; www.ppa.org.uk/news/vol_cost_presc.htm (14 June 2005).
  31. 31.
    Tully MP, Seston EM, Cantrill JA. Motivators and barriers to the implementation of pharmacist-run prescription monitoring and review services in two settings. Int J Pharm Prac 2000;8(3):188–197.Google Scholar
  32. 32.
    Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Prac 2003;53:600–606.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • Jessica P. Clemerson
    • 1
    Email author
  • Katherine Payne
    • 3
  • Paul Bissell
    • 2
  • Claire Anderson
    • 1
  1. 1.Centre for Pharmacy, Health and SocietyUniversity of NottinghamNottinghamUK
  2. 2.University of Sheffield, School of Health and Related Research (ScHARR)SheffieldUK
  3. 3.The North West Genetics Knowledge Park (Nowgen)The University of ManchesterManchesterUK

Personalised recommendations